Public procurement notice: Prior Information Notice Without Call For Competition
Published: 2017-05-31
Buyer: Arden & GEM CSU
Country: UK
Region: EAST OF ENGLAND
Contract type: Services
CPV classification: 85100000: Health services

Technical requirements: NHS Arden and Greater East Midlands Commissioning Support Unit on behalf of NHS England — North Midlands (the Commissioner) is seeking to gain a greater understanding of the potential market to inform future commissioning of Bowel Cancer Screening Hub by asking Providers to respond to a market assessment questionnaire by 12:00 noon 12.7.2017.
The Bowel Cancer Screening HUB has responsibility to ensure that the invitation, result and sample testing service process runs in a timely and effective manner, including managing non-responders. This can play an indirect but important role in improving uptake rates for Bowel Cancer and Bowel Scope screening.
Bowel Cancer Screening aims to detect bowel cancer at an early stage (in people with no symptoms), when treatment is more likely to be effective. Bowel Cancer Screening can also detect polyps.
The Programme offers screening every 2 years to all men and women aged 60 to 74. A Faecal Occult Blood (FOB) test kit is sent out to the eligible person's home address along with step-by-step instructions for completing the test at home and sending the samples to the hub laboratory. Results are then sent to the person and the persons GP.
Around 98 in 100 people will receive a normal result and will be returned to routine screening. Around 2 in 100 people will receive an abnormal result. They will be referred for further investigation and usually offered a colonoscopy. Bowel Scope Screening is a new part of the Bowel Cancer Screening Programme and is currently being rolled out across the area.
It involves a once-only flexible sigmoidoscopy being offered for all people around the time of their 55th birthday.
The aim of this screening test is to detect and remove any polyps in the rectum and sigmoid colon. Some of these patients will also be referred on for further investigations if the polyps are identified as high risk. It is estimated that about 1 person in every 300 will have colorectal cancer found during Bowel Scope Screening.
An expression of interest in this market assessment exercise will not automatically entitle involvement in any future procurement exercise. The subsequent procurement will be advertised separately and all organisations wanting to participate will need to respond to the procurement advertisement when published.
To express an interest please: i) Register on the portal https://ardengemcsu.bravosolution.co.uk ii) Express interest by a) logging-in to the Arden and GEM CSU e-Tendering portal b) Selecting response to advert and PQQ (ref: pqq_404), c) select Open Access PQQ, d) search for and access listing related to this contract and view details e) click on Express Interest link. iii) Once you have expressed interest, access the My PQQs page where you can complete the questionnaire. You must then submit your reply using the ‘Submit Response’ button at the top of the page. If you require any further assistance consult the on-line help/contact the help-desk; Phone:0800 368 4850 E-mail help@bravosolution.co.uk